Brace Pharma Capital is a strategic investment company formed by EMS S/A, the largest pharmaceutical company in Brazil, and high net worth biotech investors. We invest in innovative, life changing therapies for diseases with a high degree of unmet medical need and insufficient treatment options If you would like to be considered as a candidate investment company please email us at info@bracepharma.com.
View Top Employees from Brace Pharma CapitalWebsite | http://www.bracepharma.com |
Revenue | $5 million |
Employees | 55 (55 on RocketReach) |
Founded | 2012 |
Address | 55 Ivan Allen Jr Blvd NW Suite 525, Atlanta, Georgia 30303, US |
Phone | (240) 403-7153 |
Technologies |
JavaScript,
HTML,
PHP
+15 more
(view full list)
|
Industry | Biotechnology, Venture Capital and Private Equity Principals, Drug Stores & Pharmacies, Biopharmaceuticals, Retail, Science and Engineering, Biotech, Clinical Development, Emerging Markets, FDA, Healthcare, International Business, Pharma, Pharmaceuticals industry, Pharmaceutics, Product Development, R&D, Research & Development, Strategic Partnership |
Web Rank | 30 Million |
Keywords | Brace Pharma Capital |
Competitors | Bristol Meyers Squibb, Genentech, Merck, Sumitomo Dainippon Pharma, Teva Pharmaceuticals UK |
SIC | SIC Code 28 Companies, SIC Code 283 Companies |
NAICS | NAICS Code 32541 Companies, NAICS Code 3254 Companies, NAICS Code 32 Companies, NAICS Code 325 Companies |
Looking for a particular Brace Pharma Capital employee's phone or email?
The Brace Pharma Capital annual revenue was $5 million in 2024.
Todd Brady is the Director of Finance and Investments of Brace Pharma Capital.
55 people are employed at Brace Pharma Capital.
Brace Pharma Capital is based in Atlanta, Georgia.
The NAICS codes for Brace Pharma Capital are [32541, 3254, 32, 325].
The SIC codes for Brace Pharma Capital are [28, 283].